Homeopathic treatment of heavy menstrual bleeding

A double blind, randomized, placebo-controlled pilot trial of individualized homeopathic medicines in heavy menstrual bleeding

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038645

Enrollment

Registered

2021-12-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N92- Excessive, frequent and irregularmenstruation

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies: Intervention is planned as administering individualized homeopathic medicines in centesimal potencies. Each dose will consi

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Eligibility

Inclusion criteria

Inclusion criteria: 1. Heavy menstrual bleeding (HMB) as substantiated with a Pictorial blood assessment chart (PBAC) score of 100-185 2. Age: 18-45 years 3. Patients taking oral contraceptive pills will be considered for the study after giving a wash-out period of 1 month. 4. Patients giving written consent to participate in the study. 5. Literate patients, who can read and write in Bengali and/or English

Exclusion criteria

Exclusion criteria: 1. Patients suffering from carcinoma of cervix, chronic tubo-ovarian mass, endometrial carcinoma. 2. Vulnerable population Ã¢â?¬â?? unconscious, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent. 3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness affecting quality of life or any organ failure. 4. Blood haemoglobin level less than 7g/dl. 5. Patient under tobacco chewing and / or smoking, alcoholism and / or any other form(s) of substance abuse and /or dependence. 6. Self-reported immune-compromised state. 7. Undergoing homeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Secondary

Measure	Time frame
Menorrhagia multi-attribute quality-of-life scale (MMAS) scoreTimepoint: At baseline, and after each menstrual cycle up to 3 cycles	—

Primary

Measure	Time frame
Pictorial blood assessment chart (PBAC) scoreTimepoint: At baseline, and after each menstrual cycle up to 3 cycles	—

Countries

India

Contacts

Public ContactSangita Saha

D N De Homoeopathic Medical College & Hospital

suhisna.das@gmail.com8670602660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026